Table 1.

Patients’ characteristics after hierarchical clustering. Missing values account for deviations from 100% in same categories.

Variable		CF	HF	Total
	n (%)	38 (47.5%)	42 (52.5%)	80 (100.0%)
Age
	Mean (SD)	55.6 (11.9)	61.3 (13.0)	58.6 (12.8)
Body Mass Index
	Mean (SD)	25.1 (3.8)	24.7 (4.5)	24.9 (4.2)
Diabetes Mellitus
	No	37 (97.4%)	42 (100.0%)	79 (98.8%)
Smoker
	No	36 (94.8%)	42 (100.0%)	78 (97.5%)
Cup-Size
	A	1 (2.6%)	8 (19.1%)	9 (11.3%)
	B	19 (50.0%)	13 (31.0.%)	32 (40.0%)
	C	10 (26.3%)	10 (23.8%)	20 (25.0%)
	D	4 (10.5%)	7 (16.7%)	11 (13.8%)
	E	1 (2.6%)	1 (2.4%)	2 (2.5%)
	F	0 (0.0%)	1 (2.4%)	1 (1.3%)
Side
	Right	25 (65.8%)	23 (54.8%)	48 (60.0%)
	Left	13 (34.2%)	19 (45.3%)	32 (40.0%)
Topic Cremes
	Bepanthen	16 (42.1%)	16 (38.1%)	32 (40.0%)
	No Creme	15 (39.5%)	18 (42.9%)	33 (41.3%)
	Anthyllis	4 (10.5%)	4 (9.5%)	8 (10.0%)
	Both	3 (7.9%)	4 (9.5%)	7 (8.8%)
Surgery Typ
	BET	30 (79.0%)	41 (97.6%)	71 (88.8%)
	Mastectomy	7 (18.4%)	1 (2.4%)	8 (10.0%)
	others	1 (2.6%)	0 (0.0%)	1 (1.3%)
Lymph Node surgery
	SLNB	16 (42.1%)	39 (92.9%)	55 (68.8%)
	None	12 (31.6%)	0 (0.0%)	12 (15.0%)
	ALND	10 (26.3%)	3 (7.1%)	13 (16.3%)
Chemotherapy
	None	29 (76.3%)	38 (90.5%)	67 (83.8%)
	Neo-Adjuvant	8 (21.1%)	4 (9.5%)	12 (15.0%)
	Adjuvant	1 (2.6%)	0 (0.0%)	1 (1.3%)
Lymph node irradiation
	0	24 (63.2%)	40 (95.2%)	64 (80.0%)
	1	14 (36.8%)	1 (2.4%)	15 (18.8%)
Photon Energy
	6 MV	22 (57.9%)	21 (50.0%)	43 (53.8%)
	6/15 MV	12 (31.6%)	15 (35.7%)	27 (33.8%)
	6/10 MV	4 (10.53%)	1 (2.38%)	5 (6.25%)
Boost
	Yes	20 (52.6%)	29 (69.1%)	49 (61.3%)
	No	18 (47.4%)	13 (31.0%)	31 (38.8%)